Northrop Grumman provides global pharmaceutical companies with comprehensive and full-chain CRO services for clinical research and development, improving the success rate of drug research and development, reducing risks, saving costs, and shortening the cycle. Northrop GEM was listed on the Shenzhen Stock Exchange’s Growth Enterprise Market today with the company’s stock code of 301333, the issue price of 78.88 yuan per share, and the issue price-earnings ratio of 50.13 times.
This article is reproduced from: https://www.itjuzi.com/investevent/13433968
This site is for inclusion only, and the copyright belongs to the original author.